Cargando…

Cholesterol in Relation to COVID-19: Should We Care about It?

Current data suggest that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing corona virus disease-19 (COVID-19) seems to follow a more severe clinical course in patients with cardiovascular disease (CVD), hypertension, and overweight/obesity. It appears that lipid-lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radenkovic, Dina, Chawla, Shreya, Pirro, Matteo, Sahebkar, Amirhossein, Banach, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356583/ https://www.ncbi.nlm.nih.gov/pubmed/32570882 http://dx.doi.org/10.3390/jcm9061909

Ejemplares similares

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms?
por: Sahebkar, Amirhossein, et al.
Publicado: (2016)

Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces
por: Bianconi, Vanessa, et al.
Publicado: (2020)

Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation
por: Surma, Stanisław, et al.
Publicado: (2023)

CETP inhibition in the REVEAL trial: could we aim higher?
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
por: Momtazi, Amir Abbas, et al.
Publicado: (2017)

Why we should care about ultra-rare disease
por: Harari, Sergio
Publicado: (2016)

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020)

Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies
por: Pirro, Matteo, et al.
Publicado: (2019)

Pathophysiology of Cardiovascular Complications in COVID-19
por: Petrovic, Vladimir, et al.
Publicado: (2020)

We Should Have Concerns about Risk Transfer
por: Park, Jungsun
Publicado: (2013)

Why should we be concerned about early menarche?
por: Lee, Hae Sang
Publicado: (2020)

The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu
por: Mahdavi Gorabi, Armita, et al.
Publicado: (2019)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

Low‐density lipoprotein cholesterol and stroke: How low should we go?
por: Lui, David TW, et al.
Publicado: (2020)

Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2018)

The Window Matters: A Systematic Review of Time Restricted Eating Strategies in Relation to Cortisol and Melatonin Secretion
por: Chawla, Shreya, et al.
Publicado: (2021)

“Pain Relief is an Essential Human Right”, We Should be Concerned about It
por: Imani, Farnad, et al.
Publicado: (2011)

Pain Guided Healing: Something We Should All Know About
por: Lalonde, Donald H.
Publicado: (2022)

Chloroquine and COVID-19: Should We Care about Ototoxicity?
por: Monteiro, Eduardo Machado Rossi, et al.
Publicado: (2020)

Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?
por: Han, Ki Hoon
Publicado: (2019)

Effects of statins on mitochondrial pathways
por: Mollazadeh, Hamid, et al.
Publicado: (2021)

Drucebo effect – the challenge we should all definitely face!
por: Banach, Maciej, et al.
Publicado: (2021)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Should we go “Regional” in Intensive Care?
por: Lazar, Alexandra
Publicado: (2021)

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)

Lipoprotein(a): the enemy that we still don’t know how to defeat
por: Banach, Maciej
Publicado: (2023)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Cognitive sequelae of COVID-19, a post-pandemic threat. Should we be worried about the brain fog?
por: Brutto, Oscar H. Del
Publicado: (2022)

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016)

The COVID-19 pandemic and kangaroo mother care: What should we do?
por: Hakimi, Sevil
Publicado: (2020)

Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2018)

Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

COVID-19 Vaccination. Where Are We and Where Should We Go?
por: Peña-Otero, David
Publicado: (2022)

Why Should We Care About Molecular Coevolution?
por: Codoñer, Francisco M., et al.
Publicado: (2008)

Medical Device Regulation: Should We Care About It?
por: Bianchini, Elisabetta, et al.
Publicado: (2022)

Why we should worry less about predatory publishers and more about the quality of research and training at our academic institutions
por: Wager, Elizabeth
Publicado: (2017)

The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis
por: Vahedian-Azimi, Amir, et al.
Publicado: (2022)

Special Care Dentistry and COVID-19 Outbreak: What Lesson Should We Learn?
por: Dziedzic, Arkadiusz
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ap36uvptstus6cfca66ihvurr